Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Alfuzosin | Alfuzosin may increase the hypotensive activities of Cadralazine. |
| Amifostine | Cadralazine may increase the hypotensive activities of Amifostine. |
| Diazoxide | Diazoxide may increase the hypotensive activities of Cadralazine. |
| Methylphenidate | Methylphenidate may decrease the antihypertensive activities of Cadralazine. |
| Dexmethylphenidate | Dexmethylphenidate may decrease the antihypertensive activities of Cadralazine. |
| Obinutuzumab | Cadralazine may increase the hypotensive activities of Obinutuzumab. |
| Pentoxifylline | Pentoxifylline may increase the hypotensive activities of Cadralazine. |
| Rituximab | Cadralazine may increase the hypotensive activities of Rituximab. |
| Desmopressin | Desmopressin may decrease the antihypertensive activities of Cadralazine. |
| Cyclosporine | Cyclosporine may decrease the antihypertensive activities of Cadralazine. |
| Phentermine | Phentermine may decrease the antihypertensive activities of Cadralazine. |
| Midodrine | Midodrine may decrease the antihypertensive activities of Cadralazine. |
| Eletriptan | Eletriptan may decrease the antihypertensive activities of Cadralazine. |
| Isoetharine | Isoetharine may decrease the antihypertensive activities of Cadralazine. |
| Methysergide | Methysergide may decrease the antihypertensive activities of Cadralazine. |
| Cabergoline | Cabergoline may decrease the antihypertensive activities of Cadralazine. |
| Atomoxetine | Atomoxetine may decrease the antihypertensive activities of Cadralazine. |
| Etomidate | Etomidate may decrease the antihypertensive activities of Cadralazine. |
| Zolmitriptan | Zolmitriptan may decrease the antihypertensive activities of Cadralazine. |
| Dihydroergotamine | Dihydroergotamine may decrease the antihypertensive activities of Cadralazine. |
| Amitriptyline | Amitriptyline may decrease the antihypertensive activities of Cadralazine. |
| Protriptyline | Protriptyline may decrease the antihypertensive activities of Cadralazine. |
| Methylergometrine | Methylergometrine may decrease the antihypertensive activities of Cadralazine. |
| Norepinephrine | Norepinephrine may decrease the antihypertensive activities of Cadralazine. |
| Mirtazapine | Mirtazapine may decrease the antihypertensive activities of Cadralazine. |
| Phenylephrine | Phenylephrine may decrease the antihypertensive activities of Cadralazine. |
| Phenylpropanolamine | Phenylpropanolamine may decrease the antihypertensive activities of Cadralazine. |
| Promazine | Promazine may decrease the antihypertensive activities of Cadralazine. |
| Droperidol | Droperidol may decrease the antihypertensive activities of Cadralazine. |
| Buspirone | Buspirone may decrease the antihypertensive activities of Cadralazine. |
| Nortriptyline | Nortriptyline may decrease the antihypertensive activities of Cadralazine. |
| Amoxapine | Amoxapine may decrease the antihypertensive activities of Cadralazine. |
| Doxapram | Doxapram may decrease the antihypertensive activities of Cadralazine. |
| Atropine | Atropine may decrease the antihypertensive activities of Cadralazine. |
| Lisuride | Lisuride may decrease the antihypertensive activities of Cadralazine. |
| Metaraminol | Metaraminol may decrease the antihypertensive activities of Cadralazine. |
| Trazodone | Trazodone may decrease the antihypertensive activities of Cadralazine. |
| Epinephrine | Epinephrine may decrease the antihypertensive activities of Cadralazine. |
| Sumatriptan | Sumatriptan may decrease the antihypertensive activities of Cadralazine. |
| Ergotamine | Ergotamine may decrease the antihypertensive activities of Cadralazine. |
| Nicergoline | Nicergoline may decrease the antihypertensive activities of Cadralazine. |
| Methoxamine | Methoxamine may decrease the antihypertensive activities of Cadralazine. |
| Trimipramine | Trimipramine may decrease the antihypertensive activities of Cadralazine. |
| Risperidone | Risperidone may decrease the antihypertensive activities of Cadralazine. |
| Propiomazine | Propiomazine may decrease the antihypertensive activities of Cadralazine. |
| Alfentanil | Alfentanil may decrease the antihypertensive activities of Cadralazine. |
| Fentanyl | Fentanyl may decrease the antihypertensive activities of Cadralazine. |
| Orciprenaline | Orciprenaline may decrease the antihypertensive activities of Cadralazine. |
| Phenmetrazine | Phenmetrazine may decrease the antihypertensive activities of Cadralazine. |
| Trifluoperazine | Trifluoperazine may decrease the antihypertensive activities of Cadralazine. |
| Dobutamine | Dobutamine may decrease the antihypertensive activities of Cadralazine. |
| Pseudoephedrine | Pseudoephedrine may decrease the antihypertensive activities of Cadralazine. |
| Benzphetamine | Benzphetamine may decrease the antihypertensive activities of Cadralazine. |
| Ritodrine | Ritodrine may decrease the antihypertensive activities of Cadralazine. |
| Terbutaline | Terbutaline may decrease the antihypertensive activities of Cadralazine. |
| Flupentixol | Flupentixol may decrease the antihypertensive activities of Cadralazine. |
| Bitolterol | Bitolterol may decrease the antihypertensive activities of Cadralazine. |
| Quinidine | Quinidine may decrease the antihypertensive activities of Cadralazine. |
| Almotriptan | Almotriptan may decrease the antihypertensive activities of Cadralazine. |
| Diethylpropion | Diethylpropion may decrease the antihypertensive activities of Cadralazine. |
| Salmeterol | Salmeterol may decrease the antihypertensive activities of Cadralazine. |
| Naratriptan | Naratriptan may decrease the antihypertensive activities of Cadralazine. |
| Rizatriptan | Rizatriptan may decrease the antihypertensive activities of Cadralazine. |
| Formoterol | Formoterol may decrease the antihypertensive activities of Cadralazine. |
| Dopamine | Dopamine may decrease the antihypertensive activities of Cadralazine. |
| Frovatriptan | Frovatriptan may decrease the antihypertensive activities of Cadralazine. |
| Albuterol | Salbutamol may decrease the antihypertensive activities of Cadralazine. |
| Methoxyflurane | Methoxyflurane may decrease the antihypertensive activities of Cadralazine. |
| Ergoloid mesylate | Ergoloid mesylate may decrease the antihypertensive activities of Cadralazine. |
| Isoprenaline | Isoprenaline may decrease the antihypertensive activities of Cadralazine. |
| Arbutamine | Arbutamine may decrease the antihypertensive activities of Cadralazine. |
| Dutasteride | Dutasteride may decrease the antihypertensive activities of Cadralazine. |
| Doxepin | Doxepin may decrease the antihypertensive activities of Cadralazine. |
| Nefazodone | Nefazodone may decrease the antihypertensive activities of Cadralazine. |
| Desipramine | Desipramine may decrease the antihypertensive activities of Cadralazine. |
| Propafenone | Propafenone may decrease the antihypertensive activities of Cadralazine. |
| Pergolide | Pergolide may decrease the antihypertensive activities of Cadralazine. |
| Finasteride | Finasteride may decrease the antihypertensive activities of Cadralazine. |
| Ergometrine | Ergometrine may decrease the antihypertensive activities of Cadralazine. |
| Lisdexamfetamine | Lisdexamfetamine may decrease the antihypertensive activities of Cadralazine. |
| Paliperidone | Paliperidone may decrease the antihypertensive activities of Cadralazine. |
| Arformoterol | Arformoterol may decrease the antihypertensive activities of Cadralazine. |
| Fenoterol | Fenoterol may decrease the antihypertensive activities of Cadralazine. |
| Pirbuterol | Pirbuterol may decrease the antihypertensive activities of Cadralazine. |
| Ephedra sinica root | Ephedra sinica root may decrease the antihypertensive activities of Cadralazine. |
| Ephedrine | Ephedrine may decrease the antihypertensive activities of Cadralazine. |
| Mephentermine | Mephentermine may decrease the antihypertensive activities of Cadralazine. |
| Procaterol | Procaterol may decrease the antihypertensive activities of Cadralazine. |
| Yohimbine | Yohimbine may decrease the antihypertensive activities of Cadralazine. |
| Methotrimeprazine | Methotrimeprazine may decrease the antihypertensive activities of Cadralazine. |
| Clenbuterol | Clenbuterol may decrease the antihypertensive activities of Cadralazine. |
| Bambuterol | Bambuterol may decrease the antihypertensive activities of Cadralazine. |
| MMDA | MMDA may decrease the antihypertensive activities of Cadralazine. |
| Midomafetamine | Midomafetamine may decrease the antihypertensive activities of Cadralazine. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may decrease the antihypertensive activities of Cadralazine. |
| 4-Methoxyamphetamine | 4-Methoxyamphetamine may decrease the antihypertensive activities of Cadralazine. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Cadralazine. |
| Tenamfetamine | Tenamfetamine may decrease the antihypertensive activities of Cadralazine. |
| Chlorphentermine | Chlorphentermine may decrease the antihypertensive activities of Cadralazine. |
| Dextroamphetamine | Dextroamphetamine may decrease the antihypertensive activities of Cadralazine. |